Tacromiz 0.03 % Ointment

Composition of Tacromiz 0.03 % Ointment

Tacromiz 0.03 % Ointment contains Tacrolimus 0.03% w/w ointment. It belongs to the Topical calcineurin inhibitor (immunosuppressant) class of medicines.

Uses of Tacromiz 0.03 % Ointment

• Treatment of atopic dermatitis (eczema)
• especially mild to moderate eczema and for maintenance/prevention of flare-ups when topical steroids are unsuitable

Key benefits

• Reduces eczema inflammation and redness
• Relieves itching and irritation
• Steroid-sparing option for sensitive areas (face/skin folds) under medical advice
• Helps prevent flare-ups with maintenance use

How Tacromiz 0.03 % Ointment works

Tacrolimus is a topical calcineurin inhibitor that suppresses T-cell activation by inhibiting calcineurin, reducing release of inflammatory cytokines. This decreases skin inflammation, itching and redness associated with eczema.

How to take Tacromiz 0.03 % Ointment

For external use only. Apply a thin layer to affected skin as advised by a doctor, usually twice daily until symptoms improve; may be used as maintenance (e.g., twice weekly) to prevent flares. Can be applied with or without food; avoid occlusive dressings unless prescribed. Wash hands after application (unless treating hands) and avoid contact with eyes, mouth and mucous membranes.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take the missed dose of Tacromiz as soon as you remember. If it is almost time for the next dose, skip the missed one and carry on with the usual schedule. Do not take two doses together to make up for a missed dose.

If you take too much

Taking more Tacromiz than prescribed can be harmful. If you suspect an overdose, contact a doctor or go to the nearest emergency department at once, and carry the pack or strip with you. In India the emergency number is 112.

Side effects of Tacromiz 0.03 % Ointment

Most side effects of Tacromiz are mild and settle as the body adjusts. Reported side effects include:

• Burning or stinging at application site
• itching
• redness
• skin irritation
• warmth sensation
• folliculitis
• acne
• headache
• increased sensitivity to sunlight
• skin infection (rare)

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Tacromiz 0.03 % Ointment

Warnings and precautions

Do not use on infected skin (seek treatment for infection first). Avoid excessive sunlight/UV exposure; use sunscreen/protective clothing. Not recommended for immunocompromised patients unless advised by a specialist. Do not apply to malignant or pre-malignant skin lesions. Use the smallest amount for the shortest duration needed; long-term continuous use should be avoided unless directed. Discontinue and consult doctor if severe irritation, swelling, or signs of infection occur.

Interactions with other medicines

Concomitant use with other topical immunosuppressants on the same area, phototherapy/UV therapy (increased risk with UV exposure), systemic immunosuppressants (additive immunosuppression). Strong CYP3A4 inhibitors may increase systemic tacrolimus exposure if significant absorption occurs (usually minimal with topical use).

How to store Tacromiz 0.03 % Ointment

Store below 25°C. Keep tightly closed. Protect from heat and moisture. Do not freeze.

Manufacturer and class

Manufacturer:

HBC LIFESCEINCE PVT LTD

Therapeutic class:

Dermatological (Anti-eczema/Immunomodulator)

Drug class:

Topical calcineurin inhibitor (immunosuppressant)